MOREin Mesothelioma Study

Patient
Written By Michael Lakeland

Medical Outcomes Research & Evidence in Mesothelioma

DaSH Global in collaboration with Mesothelioma UK have undertaken a prospective cross-sectional study in the UK collecting both Clinical and Patient Reported Outcomes data from a total of 503 Mesothelioma patients.

The study recruited patients via a national network of 26 Mesothelioma Cancer Nurse Specialists and received audit approval from 18 NHS Regional Trusts.

Data collected from this study is now available for research requests. Please contact andrew@dash-global.com or lee@dash-global.com

← BACK TO BLOGS ← BACK TO BLOGS
Michael Lakeland
Previous

Are you realising the promise of digital health?
Next

Has Pharma done enough to maximise real world evidence?